Abstract
Purpose
Concurrent infection with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) often occurs due to the commonality in risk factors for acquisition. Few studies have examined the effect of co-infection on health-related quality of life (HRQOL) in HIV positive individuals.
Methods
Ontario HIV Treatment Network Cohort Study (OCS) participants who completed an annual interviewer-administered questionnaire on up to three occasions were included. Generalized estimating equations (GEE) were used to assess the impact of HBV and HCV co-infection on physical and mental HRQOL component summary scores (range 0–100) as measured by the Medical Outcomes SF-36 health survey.
Results
As of March 2010, 1,223 participants had completed the questionnaire; 964 were HIV mono-infected, 128 were HIV–HBV co-infected, 112 were HIV–HCV co-infected, and 19 were HIV–HBV–HCV tri-infected. Eighty percent were male, median age 46 (IQR 40–53) years, 61 % Caucasian, median CD4 count 464 (IQR 319–636) cells/mm3, and 74 % had undetectable HIV viremia. Physical HRQOL was lower in HIV–HBV and HIV–HCV co-infected individuals (49.4 (IQR 42.0–53.9) and 48.1 (IQR 36.9–52.8) vs. 51.5 (IQR 45.0–55.4); p = 0.01 and <0.0001) compared to mono-infected individuals. In the multivariable GEE model, the negative impact of HCV remained significant (−2.18; p = 0.01) after adjusting for drug use, smoking, age, and gender. Unadjusted mental HRQOL was lower in HIV–HCV co-infected individuals (44.6 (IQR 34.6–54.0) vs. 48.9 (IQR 36.8–55.9); p = 0.03) compared to mono-infected individuals but no association of mental HRQOL with either co-infection was observed in multivariable GEE models.
Conclusions
HCV appears to negatively impact physical HRQOL suggesting a greater health burden for co-infected individuals. HBV and HCV co-infections were not related to lower mental HRQOL among people living with HIV/AIDS.
Similar content being viewed by others
References
Koziel, M. J., & Peters, M. G. (2007). Viral hepatitis and HIV infection. New England Journal of Medicine, 356, 1445–1454.
La Torre, G., Miele, L., Chiaradia, G., Mannocci, A., Reali, M., Gasbarrini, G., et al. (2007). Socio-demographic determinants of co-infections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. BMC Infectious Diseases, 7, 100–109.
Weinbaum, C. M., Sabin, K. M., & Santibanez, S. S. (2005). Hepatitis B, hepatitis C, and HIV in correctional populations: A review of epidemiology and prevention. AIDS, 19(Suppl 3), S41–S46.
Wylie, J. L., Shah, L., & Jolly, A. M. (2006). Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B and HIV infection in injection drug users in Winnipeg, Canada. BMC Public Health, 6, 229–248.
Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47, 1108–1117.
Ware, J. E., Bayliss, M. S., Mannocchia, M., Davis, G. L., & The International Hepatitis Interventional Therapy Group. (1999). Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. Hepatology, 30, 550–555.
Younossi, Z., Kallman, J., & Kincaid, J. (2007). The effects of HCV infection and management on health-related quality of life. Hepatology, 45, 806–816.
Spiegel, B. M. R., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005). Impact of hepatitis C on health-related quality of life: A systematic review and quantitative assessment. Hepatology, 41, 790–800.
Call, S. A., Klapow, J. C., Steward, K. E., Westfall, A. O., Mallinger, A. P., DeMasi, R. A., et al. (2000). Health-related quality of life and virologic outcomes in an HIV clinic. Quality of Life Research, 9, 977–985.
Protopopescu, C., Marcellin, F., Spire, B., Preau, M., Verdon, R., Peyramond, D., et al. (2007). Health-related quality of life in HIV-1-infected patients on HAART: A five-years longitudinal analysis accounting for dropout in APROCO-COPILOTE cohort (ANRS CO-8). Quality of Life Research, 16, 577–591.
Fleming, C. A., Christiansen, D., Nunes, D., Heeren, T., Thornton, D., Horsburgh, C. R., et al. (2004). Health-related quality of life of patients with HIV disease: Impact of hepatitis C coinfection. Clinical Infectious Diseases, 38, 572–578.
Kanwal, F., Gralnek, I. M., Hays, R. D., Dulai, G. S., Spiegel, B. M. R., Bozzette, S., et al. (2005). Impact of chronic viral hepatitis on health-related quality of life in HIV: Results from a nationally representative sample. American Journal of Gastroenterology, 100, 1984–1994.
Briongos-Figuero, L. S., Bachiller-Luque, P., Palacios-Martin, T., Gonzalez-Sagrado, M., & Eiros-Bouza, J. M. (2011). Assessment of factors influencing health related quality of life in HIV-infected patients. HIV Medicine, 12, 22–30.
Tsui, J. I., Bangsberg, D. R., Ragland, K., Hall, C. S., & Riley, E. D. (2007). The impact of chronic hepatitis C on health related quality of life in homeless and marginally housed individuals with HIV. AIDS and Behavior, 11(4), 603–610.
Rourke, S., Gardner, S., Burchell, A. N., Raboud, J. M., Rueda, S., Bayoumi, A. M., et al. (2012). Cohort profile: The Ontario HIV Treatment Network Cohort Study (OCS). International Journal of Epidemiology. doi:10.1093/ije/dyr230.
Ware, J. E., & Kosinski, M. (1996) The SF-36 health survey (version 2.0). Technical note. Boston, MA: Health Assessment Lab, September 20, 1996 (updates September 27, 1997).
McHorney, C. A., Ware, J. E., Ly, J. F. R., & Sherbourne, C. D. (1994). The MOS 36-item short-form health survey (SF-36): III tests for data quality, scaling assumptions and reliability across diverse patient groups. Medical Care, 32, 40–66.
Wu, A. W., Hays, R. D., Kelly, S., Malitz, F., & Bozzette, S. A. (1997). Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Quality of Life Research, 6, 531–554.
McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-item short-form health survey (SF-36): II psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 247–263.
Hays, R. D., Cunningham, W. E., Ettl, M. K., & Beck, C. K. (1995). Health related quality of life in HIV disease. Assessment, 2, 363–380.
Ware, J., Kosinski, M., Bjorner, J., Tunrer-Bowker, D., Gandek, B., & Maruish, M. (2007). User’s manual for the SF-36v2 health survey (2nd ed.). Lincoln, RI: Quality Metric Incorporated.
Sherbourne, C. D., & Stewart, A. L. (1991). The MOS social support survey. Social Science and Medicine, 32, 705–714.
Radloff, L. S. (1977). The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
Carver, C. S. (1997). You want to measure coping but your protocol’s too long: consider the brief COPE. International Journal of Behavioral Medicine, 4, 92–100.
Pearlin, L. I., & Schooler, C. (1997). The structure of coping. Journal of Health and Social Behavior, 19, 2–21.
Berger, B. E., Ferrans, C. E., & Lashley, F. R. (2001). Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Research in Nursing & Health, 24, 518–529.
Shields, M. (2004). Stress, health and the benefit of social support. Health Reports, 15, 9–38.
Liang, K. Y., & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73, 13–22.
Preau, M., Marcellin, F., Carrieri, M. P., Lert, F., Obadia, Y., Spire, B., et al. (2007). Health-related quality of life in French people living with HIV in 2003: Results from the national ANRS-EN12-VESPA Study. AIDS, 21(suppl 1), S19–S27.
Marcellin, F., Preau, M., Ravaux, I., Dellamonica, P., Spire, B., & Carrieri, M. P. (2007). Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and hepatitis C: Implications of clinical management and future research. HIV Clinical Trials, 8, 320–327.
Poynard, T., Cacoub, P., Ratziu, V., Myers, R. P., Dezailles, M. H., Mercadier, A., et al. (2002). Fatigue in patients with chronic hepatitis C. Journal of Viral Hepatitis, 9, 295–303.
Barkhuizen, A., Rosen, H. R., Wolf, S., Flora, K., Benner, K., & Bennett, R. M. (1999). Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients. American Journal of Gastroenterology, 94, 1355–1360.
Abayli, B., Canataroglu, A., & Akkiz, H. (2003). Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection. Turkish Journal of Gastroenterology, 14, 7–11.
Kallinowski, B., Haseroth, K., Marinos, G., et al. (1998). Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clinical and Experimental Immunology, 111, 269–277.
Leroy, V., Vigan, I., Mosnier, J. F., et al. (2003). Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology, 38, 829–841.
Teuber, G., Schäfer, A., Rimpel, J., Paul, K., Keicher, C., Scheurlen, M., et al. (2008). Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis. Journal of Hepatology, 49, 923–929.
Vassilopoulos, D., & Calabrese, L. H. (2003). Rheumatic manifestations of hepatitis C infection. Current Rheumatology Reports, 5(3), 200–204.
Buskila, D., Shnaider, A., Neumann, L., Zilberman, D., Hilzenrat, N., & Sikuler, E. (1997). Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Archives of Internal Medicine, 157, 2497–2500.
Kozanoglu, E., Canataroglu, A., Abayli, B., Colakoglu, S., & Goncu, K. (2003). Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatology International, 23, 248–251.
Gibson, K., Rueda, S., Rourke, S. B., Bekele, T., Gardner, S., Fenta, H., et al. (2011). Mastery and coping moderate the negative effect of acute and chronic stressors on mental health-related quality of life in HIV. AIDS Patient Care and STDs, 25, 371–381.
Jia, H., Uphold, C. R., Wu, S., Reid, K., Findley, K., & Duncan, P. W. (2004). Health-related quality of life among men with HIV infection: Effects of social support, coping and depression. AIDS Patient Care and STDs, 18, 594–603.
Van Dijk, A. P., Toet, J., & Verdurmen, J. E. E. (2004). The relationship between health related quality of life and two measures of alcohol consumption. Journal of Studies on Alcohol, 65, 241–249.
Liu, C., Johnson, L., Ostrow, D., Silvestre, A., Visscher, B., & Jacobsen, L. (2006). Predictors for lower quality of life in the HAART era among HIV-infected men. Journal of Acquired Immune Deficiency Syndromes, 42, 470–477.
Stranges, S., Notaro, J., Freudenheim, J. L., Calogero, R. M., Muti, P., Farinaro, E., et al. (2006). Alcohol drinking pattern and subjective health in a population-based study. Addiction, 101, 1265–1276.
Yee, T. T., Griffioen, A., Sabin, C. A., Dusheiko, G., & Lee, C. A. (2000). The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut, 47(6), 845–851.
Public Health Agency of Canada. (2009). HIV and AIDS in Canada. Surveillance report to December 31, 2008. Ottawa: Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada.
Acknowledgments
We gratefully acknowledge all of the people living with HIV who volunteered to participate in the OHTN Cohort Study and the work and support of the past and present members of the OCS Governance Committee: Darien Taylor, Dr. Evan Collins, Dr. Greg Robinson, Shari Margolese, Patrick Cupido, Tony Di Pede, Rick Kennedy, Michael Hamilton, Ken King, Brian Finch, Lori Stoltz, Dr. Ahmed Bayoumi, Dr. Clemon George, Dr. Curtis Cooper, Dr. Troy Grennan, Adrian Betts, Tracey Conway, and Colleen Price. We thank all the interviewers, data collectors, research associates and coordinators, nurses, and physicians who provide support for data collection and extraction. The authors wish to thank the OHTN staff and their teams for data management and IT support (Mark Fisher, Director, IT), and OCS project coordination (Samantha Robinson, Project Coordinator). The OHTN Cohort Study is supported by the Ontario Ministry of Health and Long-Term Care. Five investigators are also the recipients of salary support from the Ontario HIV Treatment Network (JR, CC, TAH), and the Canadian Institutes of Health Research (SR, KO).
Conflict of interest
There are no conflicts of interest for any of the authors.
Author information
Authors and Affiliations
Consortia
Corresponding author
Appendix: The OHTN Cohort Study Team
Appendix: The OHTN Cohort Study Team
The OHTN Cohort Study Team consists of Dr. Sean B. Rourke (Principal Investigator, University of Toronto and OHTN), Dr. Ann Burchell (Co-Principal Investigator, OHTN), Dr. Sandra Gardner (OHTN), Dr. Sergio Rueda (OHTN), Dr. Ahmed Bayoumi, St. Michael’s Hospital; Dr. Jeffrey Cohen, Windsor Regional Hospital; Dr. Curtis Cooper, The Ottawa Hospital- General Campus; Dr. Don Kilby, University of Ottawa Health Services; Dr. Mona Loutfy and Dr. Fred Crouzat, Maple Leaf Medical Clinic; Dr. Anita Rachlis and Dr. Nicole Mittmann, Sunnybrook Health Sciences Centre; Dr. Janet Raboud and Dr. Irving Salit, Toronto General Hospital; Dr. Edward Ralph, St. Joseph’s Health Care; Dr. Roger Sandre, Sudbury Regional Hospital; Dr. Marek Smieja, Hamilton Health Sciences, McMaster University Medical Centre; and Dr. Wendy Wobeser, Hotel Dieu Hospital.
Rights and permissions
About this article
Cite this article
Gillis, J., Cooper, C., Rourke, S. et al. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Qual Life Res 22, 1525–1535 (2013). https://doi.org/10.1007/s11136-012-0283-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-012-0283-7